Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hair restoration surgery has improved to transplant hair in natural groupings, but it's labor-intensive and can't fully restore normal hair density.

Artemis dysfunction might cause hair loss through telomere shortening.

Hair loss in men is common, treatable, but not curable.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

TRH stimulates human hair growth and extends the hair growth phase.

Genetics and hormones cause hair loss; finasteride treats it safely.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Minoxidil effectively treats female pattern hair loss.

Hair follicle stem cells are a practical and ethical option for nerve repair in regenerative medicine.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The new visual scale is a quick and effective way to measure hair loss in women.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hair loss gene linked to prostate issues.

The hair-growth formula with L-cystine helps protect and grow hair cells.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Treatments for hair loss vary, but cell-based options may be the future.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

5% minoxidil works better for hair growth and density, with minor irritation.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.